Douglas E. Brough
Corporate Officer/Principal en PRECIGEN, INC. .
Cargos activos de Douglas E. Brough
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - | - |
| Director Técnico/Científico/I+D | - | - |
Historial de carrera de Douglas E. Brough
Antiguos cargos conocidos de Douglas E. Brough.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GENVEC INC | Director Técnico/Científico/I+D | 01/09/2013 | 16/06/2017 |
Formación de Douglas E. Brough.
| Purdue University | Undergraduate Degree |
| Idaho State University | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Francia | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 5 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Douglas E. Brough
- Experiencia
